Updated December 2022. Changes for 2023 are indicated in red.
The measure is approved for traditional MIPS submission pathway only.
Care Setting: Ambulatory Care: Clinician Office/Clinic
- IRIS Registry QCDR for EHR: groups and individuals
- IRIS Registry QCDR manual data entry: groups and individuals
Measure Type: Outcome
NQS Domain: Effective Clinical Care
Meaningful Measure Area: Management of Chronic Conditions
Description: Percentage of eyes of patients who underwent cataract surgery combined with a trabeculectomy or an aqueous shunt procedure who had their visual acuity improve 1 or 2 more lines from their preoperative visual acuity between 3 and 6 months post-operatively. Weighted average of performance rates reported.
Risk Adjusted: No
Performance Rate: 3, weighted average of performance rates reported
High Priority Measure: Yes
Inverse Measure: No
To Which Patients Does the Measure Apply?
Denominator: Eyes of patients aged between 40 and 85 years with a diagnosis of open-angle glaucoma, pigmentary glaucoma, primary open-angle glaucoma, pseudoexfoliation glaucoma or chronic angle glaucoma and who underwent cataract surgery combined with a trabeculectomy or an aqueous shunt procedure.
There are three criteria for inclusion of a patient into the denominator.
- Patient characteristics: Description located in “Denominator” (see above).
- Diagnosis codes (ICD-10-CM): Codes located in “Diagnosis Codes.”
- Procedure codes (CPT): Codes located in “CPT Codes.”
The quality measure also has exclusions for the denominator.
Diagnosis of glaucoma with documentation of severity
- Open-angle glaucoma, unspecified (ICD-10: H40.10X1, H40.10X2, H40.10X3)
- Pigmentary glaucoma (ICD-10: H40.1311, H40.1312, H40.1313, H40.1321, H40.1322, H40.1323, H40.1331, H40.1332, H40.1333,
H40.1391, H40.1392, H40.1393)
- Primary open angle glaucoma (ICD-10: H40.1111, H40.1112, H40.1113, H40.1121, H40.1122, H40.1123, H40.1131, H40.1132, H40.1133)
- Pseudoexfoliation glaucoma (ICD-10: H40.1411, H40.1412, H40.1413, H40.1421, H40.1422, H40.1423, H40.1431, H40.1432, H40.1433)
- Chronic angle glaucoma (ICD-10: H40.2211, H40.2212, H40.2213, H40.2221, H40.2222, H40.2223, H40.2231, H40.2232, H40.2233, H40.2311, H40.2312, H40.2313, H40.2321, H40.2322, H40.2323, H40.2331, H40.2332, H40.2333, H40.2411, H40.2412, H40.2413, H40.2421, H40.2422, H40.2423, H40.2431, H40.2432, H40.2433)
- Cataract surgery (CPT: 66840, 66850, 66852, 66920, 66930, 66940, 66982, 66983, 66984, 66987, 66988)
WITHOUT Modifier -55 (Postoperative management only) OR Modifier -56 (Preoperative management only)
- Trabeculectomy procedure (CPT: 66170, 66172 with modifier RT, LT, -50)
- Aqueous shunt procedure (CPT: 66179, 66180, 66183, 0449T, or 0450T, with modifier RT, LT, -50)
How to Report the Measure
Numerator: Eyes of patients with a preoperative visual acuity better than 20/200 and 2 or more lines from their preoperative visual acuity and between 3 and 6 months postoperatively.
Eyes of patients with a preoperative visual acuity of 20/200, and an improvement of 2 or more lines from their preoperative visual acuity between 3 and 6 months postoperatively
Eyes of patients with a preoperative visual acuity of 20/400, and an improvement of 1 or more lines from their preoperative visual acuity between 3 and 6 months postoperatively
Percent change between preoperative visual acuity and the visual acuity measured between 3 and 6 months postoperatively.
Calculation is based on the visual acuity of the eye that underwent the combined procedure.
- Eyes with absolute glaucoma blindness (ICD-10: H44.511, H44.512, H44.513)
- Visual acuity findings: Count fingers (CF or FC), Hand motion (HM), Light perception (LP), No light perception (NLP)
How CMS Scores Your Performance
See the QPP resource library for benchmarks.
This measure has been developed by the H. Dunbar Hoskins Jr. MD Center for Quality Eye Care of the American Academy of Ophthalmology. The measure is not a clinical guideline and does not establish a medical standard. It has not been tested in all possible applications.
The measure, while copyrighted, can be reproduced and distributed with appropriate credit, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. The American Academy of Ophthalmology encourages use of the measure by other health care professionals, where applicable.
Commercial use is defined as the sale, license or distribution of the measures for commercial gain, or incorporation of some or all of a measure into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the measures require a license agreement between the user and the American Academy of Ophthalmology. Neither the Academy nor its members shall be responsible for any use of the measures.
THE MEASURE AND SPECIFICATIONS ARE PROVIDED “AS IS,” WITHOUT WARRANTY OF ANY KIND.
© 2018-2023 American Academy of Ophthalmology. All rights reserved. Limited proprietary coding from Current Procedural Terminology (CPT®) is contained in the measure specifications. Users of this code set should obtain all necessary licenses. The Academy disclaims all liability for use or accuracy of the coding contained in these measure specifications. CPT® contained in the measures specifications is copyright 2023 American Medical Association.